Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 18

The DOI matches its Crossref record.

A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release

Lin, Xia, Xu, Yuhong, Tang, Xing, Zhang, Yan, Chen, Jian, Zhang, Yu, He, Haibing, Yang, Ziyi·2015·Pharmaceutical Research
DOI 10.1007/s11095-015-1731-1
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11095-015-1731-1

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 41

  1. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev. 1999;99(11):3181–98. · DOI · Paper page
  2. Heres S, Lambert M, Vauth R. Treatment of early episode in patients with schizophrenia: the role of long acting antipsychotics. Eur Psychiatry. 2014;29 Suppl 2(14):1409–13. · DOI
  3. Hoybye C, Christiansen JS. Growth hormone replacement in adults—current standards and new perspectives. Best Pract Res Clin Endocrinol Metab. 2015;29(1):115–23. · DOI
  4. Jiang Y, Wang F, Xu H, Liu H, Meng Q, Liu W. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation. Int J Pharm. 2014;475(1–2):475–84. · DOI
  5. Doan TV, Couet W, Olivier JC. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int J Pharm. 2011;414(1–2):112–7. · DOI
  6. Hu Z, Liu Y, Yuan W, Wu F, Su J, Jin T. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids Surf B: Biointerfaces. 2011;86(1):206–11. · doi:10.1016/j.colsurfb.2011.03.043
  7. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1):5–24. · DOI · Paper page
  8. Schwendeman SP, Shah RB, Bailey BA, Schwendeman AS. Injectable controlled release depots for large molecules. J Control Release. 2014;190:240–53. · DOI · Paper page
  9. Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm. 2008;364(2):298–327. · DOI · Paper page
  10. Wang J, Wang BA, Schwendeman SP. Characterization of the initial burst release of a model peptide from poly(D, L-lactide-co-glycolide) microspheres. J Control Release. 2002;82(2–3):289–307. · DOI · Paper page
  11. Yang J, Wilson M, Celniker A. Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. J Control Release. 1997;49(97):193–205(13).
  12. Ereshefsky L, Mannaert E. Pharmacokinetic profile and clinical efficacy of long-acting risperidone: potential benefits of combining an atypical antipsychotic and a new delivery system. Drugs R&D. 2005;6(3):129–37. · DOI
  13. Eerdekens M, Van Hove I, Remmerie B, Mannaert E. Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizophr Res. 2004;70(1):91–100. · DOI · Paper page
  14. Sun F, Sui C, Teng L, Liu X, Teng L, Meng Q, et al. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres. Int J Pharm. 2010;397(1–2):44–9. · doi:10.1016/j.ijpharm.2010.06.042
  15. Luan X, Bodmeier R. Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles. Eur J Pharm Biopharm. 2006;63(2):205–14. · DOI
  16. Su Z, Sun F, Shi Y, Jiang C, Meng Q, Teng L, et al. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D, L-lactide-co-glycolide) microsphere. Chem Pharm Bull (Tokyo). 2009;57(11):1251–6. · DOI
  17. Husmann M, Schenderlein S, Luck M, Lindner H, Kleinebudde P. Polymer erosion in PLGA microparticles produced by phase separation method. Int J Pharm. 2002;242(1–2):277–80. · DOI
  18. Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microsphere size provides enhanced control of drug release rate. J Control Release. 2002;82(1):137–47. · DOI · Paper page
  19. Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors. Pharm Res. 2003;20(7):1055–62. · DOI · Paper page
  20. Gao Z, Ding P, Zhang L, Shi J, Yuan S, Wei J, et al. Study of a pingyangmycin delivery system: Zein/Zein-SAIB in situ gels. Int J Pharm. 2007;328(1):57–64. · doi:10.1016/j.ijpharm.2006.07.048
  21. Kraeling RR, Barb CR, Rampacek GB, Thompson Jr DL, Gibson JW, Sullivan SA, et al. Luteinizing hormone response to controlled-release deslorelin in estradiol benzoate primed ovariectomized gilts. Theriogenology. 2000;53(9):1681–9. · doi:10.1016/s0093-691x(00)00307-1
  22. Shi X, Lin X, Yao C, Shen L, Feng Y. Injectable long-acting in situ forming systems for Radix Ophiopogonis polysaccharide. Int J Biol Macromol. 2015;72:553–9. · DOI
  23. Okumu FW, Dao LN, Fielder PJ, Dybdal N, Brooks D, Sane S, et al. Sustained delivery of human growth hormone from a novel gel system: SABER. Biomaterials. 2002;23(22):4353–8. · DOI
  24. Pechenov S, Shenoy B, Yang MX, Basu SK, Margolin AL. Injectable controlled release formulations incorporating protein crystals. J Control Release : Off J Control Release Soc. 2004;96(1):149–58. · DOI
  25. Lin X, Yang S, Gou J, Zhao M, Zhang Y, Qi N, et al. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo. J Mater Sci Mater Med. 2012;23(2):443–55. · DOI
  26. Lu Y, Tang X, Cui Y, Zhang Y, Qin F, Lu X. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats. Eur J Pharm Biopharm. 2008;68(2):422–9. · DOI
  27. Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001;73(2–3):121–36. · DOI · Paper page
  28. Lu YX, Yu YL, Tang X. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. J Pharm Sci. 2007;96(12):3252–62. · DOI
  29. Qi F, Wu J, Yang T, Ma G, Su Z. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification. Acta Biomater. 2014;10(10):4247–56. · DOI
  30. Qi F, Wu J, Fan QZ, He F, Tian GF, Yang TY, et al. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability. Colloids Surf B: Biointerfaces. 2013;112(3):492–8. · DOI
  31. Piacentini E, Drioli E, Giorno L. Membrane emulsification technology: twenty-five years of inventions and research through patent survey. J Membr Sci. 2014;468(20):410–22. · doi:10.1016/j.memsci.2014.05.059
  32. Thomas C, Gupta V, Ahsan F. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles. Pharm Res. 2010;27(5):905–19. · DOI
  33. Tran VT, Benoit JP, Venier-Julienne MC. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int J Pharm. 2011;407(1–2):1–11. · DOI · Paper page
  34. Procter BG, Chappel CI. Subchronic toxicity studies of sucrose acetate isobutyrate (SAIB) in the rat and dog. Food Chem Toxicol. 1998;36(2):101–10. · doi:10.1016/s0278-6915(97)80301-8
  35. Reynolds RC. Metabolism and pharmacokinetics of sucrose acetate isobutyrate (SAIB) and sucrose octaisobutyrate (SOIB) in rats, dogs, monkeys or humans: a review. Food Chem Toxicol. 1998;36(2):95–9. · doi:10.1016/s0278-6915(97)00123-3
  36. Reynolds RC, Chappel CI. Sucrose acetate isobutyrate (SAIB): historical aspects of its use in beverages and a review of toxicity studies prior to 1988. Food Chem Toxicol. 1998;36(2):81–93. · doi:10.1016/s0278-6915(97)80300-6
  37. Phillips JC, Kingsnorth J, Rowland I, Gangolli SD, Lloyd AG. Studies on the metabolism of sucrose acetate isobutyrate in the rat and in man. Food Cosmet Toxicol. 1976;14(5):375–80. · doi:10.1016/s0015-6264(76)80172-1
  38. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res. 1993;27(9):1135–48. · DOI · Paper page
  39. Huffman K, Casey D. Effect of carboxyl end groups on hydrolysis of polyglycolic acid. J Polym Sci Polym Chem Ed. 1985;23(7):1939–54. · DOI
  40. Kazazi-Hyseni F, Zandstra J, Popa ER, Goldschmeding R, Lathuile AA, Veldhuis GJ, et al. Biocompatibility of poly(d, l-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injection. Int J Pharm. 2015;482(1–2):99–109. · DOI
  41. Pajander J, Soikkeli AM, Korhonen O, Forbes RT, Ketolainen J. Drug release phenomena within a hydrophobic starch acetate matrix: FTIR mapping of tablets after in vitro dissolution testing. J Pharm Sci. 2008;97(8):3367–78. · doi:10.1002/jps.21236

Cited by

See all 18

Metadata

Authors
Lin, X., Xu, Y., Tang, X., Zhang, Y., Chen, J., Zhang, Y., He, H., & Yang, Z.
Venue
Pharmaceutical Research
Publisher
Springer Science and Business Media LLC
Published
2015-06-16
Volume
32
Issue
11
Pages
3708-3721
ISSN
  • 0724-8741
  • 1573-904X
DOI
10.1007/s11095-015-1731-1
Cited by
18
References
0
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release. https://app.cochat.ai/papers/10.1007/s11095-015-1731-1
The paper
Lin, X., Xu, Y., Tang, X., Zhang, Y., Chen, J., Zhang, Y., He, H., & Yang, Z. (2015). A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release. Pharmaceutical Research. https://doi.org/10.1007/s11095-015-1731-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.